Stocks · Health care · Pharmaceutical Preparations

Aktis Oncology, Inc.

AKTS

United States Fiscal year ends December CIK 0002035832 Results filed 13 Aug 2026

Add to watchlist

What the insiders did Net buying

Bought (12 mo)

$114.31M

out of their own pocket, the only kind of buying there is

Sold (12 mo)

$3.23M

$0.00 on a plan · $3.23M straight out of an exercise

Sold at will

$0.00

0 of 11 sales

Net

+$111.08M

+$114.31M against sales at will